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Abstract
Background: CD4+ T lymphocyte counts are the most important indicator of disease progression and success of
antiretroviral treatment in HIV infection in resource limited settings. The nationwide reference range of CD4+ T
lymphocytes was not available in India. This study was conducted to determine reference values of absolute CD4+
T cell counts and percentages for adult Indian population.
Methods: A multicentric study was conducted involving eight sites across the country. A total of 1206
(approximately 150 per/centre) healthy participants were enrolled in the study. The ratio of male (N = 645) to
female (N = 561) of 1.14:1. The healthy status of the participants was assessed by a pre-decided questionnaire. At
all centers the CD4+ T cell count, percentages and absolute CD3+ T cell count and percentages were estimated
using a single platform strategy and lyse no wash technique. The data was analyzed using the Statistical Package
for the Social Scientist (SPSS), version 15) and Prism software version 5.
Results: The absolute CD4+ T cell counts and percentages in female participants were significantly higher than the
values obtained in male participants indicating the true difference in the CD4+ T cell subsets. The reference range
for absolute CD4 count for Indian male population was 381-1565 cells/μL and for female population was 447-1846
cells/μL. The reference range for CD4% was 25-49% for male and 27-54% for female population. The reference
values for CD3 counts were 776-2785 cells/μL for Indian male population and 826-2997 cells/μL for female
population.
Conclusion: The study used stringent procedures for controlling the technical variation in the CD4 counts across
the sites and thus could establish the robust national reference ranges for CD4 counts and percentages. These
ranges will be helpful in staging the disease progression and monitoring antiretroviral therapy in HIV infection in
India.
Introduction
CD4 + T lymphocytes play a central regulatory role in
the immune response. The decrease in CD4+ T cell
numbers can compromise the normal immune functions
of the body. The number of CD4+ T cells in circulation
provides important information about the immune com-
petence of an individual. Hence estimation of CD4+ T
cells is an important parameter in immune deficiency
disorders. The clinical applications of immunophenotyp-
ing of CD4+ T cells include the diagnosis of immunode-
ficiency disorders, the evaluation of immune-mediated
diseases, the assessment of immune reconstitution fol-
lowing stem cell transplantation and the monitoring of
disease progression in Human Immunodeficiency Virus
(HIV) infection.
HIV infects CD4+ T lymphocytes selectively and
causes the destruction of CD4+ T cells directly as well
as indirectly leading to gradual loss of the CD4+ T cell
numbers in peripheral circulation. Hence, the CD4+ T
cell counts are being used to monitor the disease
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any medium, provided the original work is properly cited.progression in HIV infection, to decide the threshold for
initiation of anti-retro viral therapy, to monitor the effi-
cacy of ART and to initiate prophylactic treatment for
opportunistic infections (OIs) [1,2].
The CD4+ T cell counts are known to be influenced
by race and environmental factors [3-9]. Hence, it is
important to establish the reference ranges for the CD4
+ T cell counts in the target population to understand
the extent of immune dysfunction. The information on
the lower limits of the CD4+ T cell count in normal
healthy population is necessary to decide the threshold
for initiation and monitoring of ART. India is one of the
countries affected significantly by HIV and has approxi-
mately 2.4 million people living with HIV/AIDS [10].
Some of the recent studies have shown that the treat-
ment at higher CD4+ T cell numbers may be beneficial
in reducing the clinical events and death. WHO has
already recommended increase of threshold for initiating
ART to 350 cells/μL. It is important to determine the
reference CD4+ T cell values to ensure that ART is not
initiated when CD4+ T cell counts are in normal range,
in case the threshold is increased further. No such
ranges are available for Indian population based on a
multi-centric well designed study. Many of the pub-
lished Indian studies had inadequate sample size and
hence, the results from these studies cannot be general-
ized. Only one study presented data with adequate sam-
ple size that included populations from different parts of
the country, however this study established only the
reference range for CD4+ T cell percentages and not for
absolute counts [11]. The comparison of the published
data on the CD4+ T cells count in healthy Indian adult
population and other parts of the world showed that the
CD4+ T cell counts differ with the population, suggest-
ing that each population should have its own reference
range for lymphocyte subsets [12].
This report presents data from a multicentric study
carried out to define the reference ranges of the abso-
lute CD4 + T cell counts and CD4+ T cell percentages
from healthy Indian adults using a standard protocol to
reduce the variability in both sample preparation and
flow cytometer operation. The influence of sex, age, eco-
nomic status, marital status, smoking, alcohol consump-
tion on CD4+ T cell count was also evaluated.
Methods
Study participants
The study was conducted at eight centers across four
geographical zones of the country; Post Graduate Insti-
tute of Medical Education & Research, Chandigarh and
All India Institute of Medical Sciences, New Delhi from
the north zone; National AIDS Research Institute, Pune
and JJ Hospitals and Grant Medical College, Mumbai
from the west zone; Y.R. G Centre for AIDS Research
and Education, Chennai and National Institute of Men-
tal Health and Neuro Sciences, Bengaluru from the
south zone and School of Tropical Medicine, Kolkata
and Regional Medical Research Centre, Dibrugarh from
the east zone. A total of 1206 healthy individuals
(approximately 150/center and 300/region) were
enrolled. The institutional Ethics Committees of all the
centers approved the study. The required information
and blood samples were collected after obtaining written
informed consent.
The participants 18 years of age or older were enrolled
in the study. The healthy status of the participants was
assessed by a pre-decided questionnaire which included
information on history of recent (within the last 3
months) episode of fever, rigors, sweats, fatigue, weight
Loss, diarrhoea, the information on the history of tuber-
culosis and asthma. Additionally, the history of vaccina-
tion, blood transfusion, allergy, and major surgery was
obtained to assess their healthy status. The participants
giving history of the recent enteric, respiratory infections
and malaria were excluded. Participants with symptoms,
investigations and treatment suggestive of tuberculosis,
with history of vaccination or blood transfusion within
last one year, autoimmune diseases were excluded. The
female participants with pregnancy were also excluded.
The data was collected on age, sex, marital status, occu-
pation, economic status (as self graded family income),
place of origin and habits like smoking and alcohol con-
sumption using the modified scale [13,14].
Sample collection and processing
Five mL of Whole blood sample was collected in
K3EDTA evacuated tubes between 9 AM to 12 noon
from all participants at all sites. The samples were pro-
cessed for CD4+ T cell count estimation on the same
day. The results were entered in a structured database.
CD4 count estimation
The CD4+ T cell count estimation was carried out using
the standard flow cytometers adapted to single platform
technology. The FACSCalibur (Becton Dickinson, USA)
was used by seven participating centers except once
from South India. This center used EPIX XL-MCL
(Beckman Coulter Inc, CA, USA).
For the FACSCalibur, 20 μL of liquid antibody reagent
(MultiTEST CD3 FITC, CD4 PE, CD45 PerCP, Cat
no.340402, Becton Dickinson, USA) and 50 μLo fw h o l e
blood was added to the TruCOUNT tube (Cat No:
340334, Becton Dickinson) containing the reference
beads. The tube was vortexed and incubated at ambient
temperature in dark for 15 minutes. The RBCs were
lysed using 450 μl of 1:10 diluted lysing solution (FAC-
Slysing solution, Cat No: 349202, Becton Dickinson,
USA) for 15 minutes in the dark at ambient
Thakar et al. AIDS Research and Therapy 2011, 8:35
http://www.aidsrestherapy.com/content/8/1/35
Page 2 of 9temperature. The stained sample was acquired on flow-
cytometer (FACSCalibur, Becton Dickinson, USA) and
analyzed using the MultiSET software (BD Biosciences).
In brief, the CD3+, CD4+ T cell populations were iden-
tified using the logarithmic amplification of fluorescence
parameters (FL1, FL2, FL3 i.e. FITC, PE and PerCP
fluorescent dye conjugated with monoclonal antibodies
against CD3, CD4 and CD45 respectively). Forward scat-
ter and side scatter (SSC-H) signals were measured
using a linear scale. After acquiring data up to 100, 000
events per sample, a gate (R1) was automatically set on
the lymphocyte cluster (SSC-H low/CD45 PerCP high+
cells). The second two-parameter dot plot (FL1 vs FL2)
was automatically generated showing double positive
(CD3+/CD4+) T cells in upper right region. Percent and
absolute counts of CD4+, CD3+ T lymphocytes were
then generated by the MultiSET software.
For the EPICS XL-MCL, 10 μL of liquid antibody
reagent (CYTO-STAT
® triCHROME™ CD8-FITC/
CD4-RD1/CD3-PC5, Beckman Coulter Inc.) and 100 μL
of whole blood was added to the Coulter tube and incu-
bated in the TQ-Prep (Beckman Coulter Inc., CA, USA)
for 10 minutes. The TQ-Prep automatically adds the
lysis, stabilizer and fixative to the tubes, to which 100
μL of Flowcount (Beckman Coulter Inc.) is added manu-
ally. The tube was vortexed and analyzed with EPICS
XL-MCL. Forward scatter and side scatter (SS) signals
were measured using a linear s c a l et og a t et h el y m p h o -
cytes. From the gated lymphocyte population, the CD4+
T-cell populations were identified using the logarithmic
amplification of fluorescence parameters (FL2 and FL4,
i.e. PE and PC5 fluorescent dyes conjugated with mono-
clonal antibodies against CD4 and CD3, respectively).
After the acquisition of events, a gate was automatically
set on the lymphocyte cluster (SS/FS). The two-para-
meter dot plot (FL4 vs FL2) was automatically generated
showing double positive (CD3+/CD4+) T-cells in upper
right region. Percent and absolute counts of CD4+ T
lymphocytes were then generated by the System II
software.
Quality control
To ensure the optical alignment of the equipment and
fluorescence compensation settings, the calibration
beads (CaliBRITE™3) were run every day and the com-
pensation was assessed using the FACSComp software
for FACSCalibur. While for EPICS XL-MCL, the align-
ment and compensation was ensured using the Flow-
Check fluorospheres and the data was analyzed using
Flow-Set beads each day before running of samples. As
an internal quality control, all the centers ran the com-
mercially available stabilized blood samples before the
samples and the samples were run only when the con-
trols showed less than 10% variation as compared to the
values obtained in the previous run. All the centers suc-
cessfully participated (3 times per year) in external profi-
ciency testing programme run either by international
program for Quality Assessment and Standardization for
Immunological Measures(QASI) from Canada or the
United Kingdom National External Quality Assurance
Service (UKNEQAS) from United Kingdom for lympho-
cyte subset estimation.
The variation between the CD4+ T cell count and
percentages obtained using the two methodologies
(FACSCalibur and EPICS XL-MCL) was assessed using
the same stabilized blood samples tested by both the
machines at two different centers. These samples
included 30 replicates of Immuno Trol (Lot# 7587024,
Beckman Coulter, USA) and samples received under the
proficiency programme from UKNEQAS (N = 22). The
%CV and correlation coefficient(r) was calculated for
both the categories of the samples. The results are given
in the table 1. The variation (%CV) between the values
obtained for absolute CD4 counts was 5.17% and 7.19%
for the Immuno Trol and proficiency samples respec-
tively whereas for CD4% the %CV was 7.04% and 4.6%
for the Immuno Trol and proficiency samples respec-
tively. The correlation coefficient (r) ranged between
0.891 and 0.993 for all the values.
Data analysis
The data was analyzed using the Statistical Package for
the Social Scientist (SPSS, version 15) and Prism soft-
ware version 5. Patients were stratified into the respec-
tive geographical zones on the basis of their place of
origin before the analysis. The mean, median and stan-
dard deviation values were calculated for absolute CD4
+ T cell count and percentages. The frequency of distri-
bution of absolute CD4+ T cell count and percentages
was analyzed for each geographical region. The result of
the Wilks-Shapiro test for normality was significant, the
data were considered to have a non-Gaussian distribu-
tion, and the reference range was defined as the central
95% of the area under the distribution curve of values (i.
e. from 2.5 to 97.5%) Differences between genders were
estimated using the Mann-Whitney U test was used to
estimate the differences between the CD4 counts and
percentages among the individuals with different demo-
graphics such as gender, age, nutrition, marital status,
economic status and habits such as alcohol use, and
smoking. P values less than 0.05 were considered to be
significant for all analyses.
Results
Demographic characteristics
A total of 1206 healthy participants were enrolled in the
study with a ratio of male (N = 645) to female (N =
561) of 1.14:1. Of 1206, 305 subjects belonged to the
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to Southern region of India. The ratio of male to female
r a n g e di ne a c hr e g i o nf r o m1 : 1t o1 . 5 :1 .N i n e t yn i n e
percent participants were from age group of 18-50
years. The mean age of male (31 years, range: 17-72)
and female (31 years, range: 18-59) participants were
similar. Of these 1206 subjects, 723 were married and
428 were unmarried or single. For the remaining partici-
pants, the status was not known. Of the 1206 partici-
pants, 75% reported medium level income (Rs. 15000-
25000/month), 17% low level income(less than Rs.
15000/month) and 8% reported high level income (more
than Rs. 25000/month). Only 5 subjects were habitual
alcohol consumers (more than 21 measures/week), 108
were occasional (1-21 measures/week) where as 1091
reported no alcohol consumption. Similarly, 29 were
habitual smokers (more than 5/day), 60 were occasional
(1-5/day) and 1115 did not smoke at all.
Absolute CD4+ T cell counts
The overall mean absolute CD4+ T cell count was 919
± 312 cells/μL (median 877, range: 302-2371 cells/μL).
Ninety eight percent of the study population showed
absolute CD4 counts between 400-2000 cells/μL( F i g -
u r e1 ) .T h e1 7m a l ea n d6f e m a l ep a r t i c i p a n t ss h o w i n g
C D 4c o u n t sl e s st h a n4 0 0c e l l s / μL are distributed
throughout the four geographical regions and not con-
founded to any particular region. The absolute CD4 +
T cell counts in female (mean: 995 ± 335, median: 953
cells/μL) were significantly higher than CD4+ T cell
counts in male (mean: 852 ± 273, median: 822 cells/
μL) participants. The region wise absolute CD4+ T cell
counts from male and female study participants are
given in table 2. The values were significantly higher in
female than male participants in all the regions. Also
there was significant difference amongst the mean
CD4+ T cell counts of the female participants from all
four geographical regions (p < 0.05). Whereas the CD4
counts of male participants from North and East
regions and from South and West regions did not dif-
fer significantly. The absolute CD4 + T cell counts of
the participants from Southern region were signifi-
cantly higher than the CD4 counts of the participants
from the other regions with the lowest CD4+ T cell
counts in the participants from the Eastern region
(Table 2). Since the normal distribution could not be
achieved for absolute CD4 counts (both region and
gender wise), the 2.5% and 97.5% percentile covering
95% of the population was considered to be the refer-
ence range for absolute CD4+ T cell counts. The refer-
ence range for absolute CD4+ T cell count for Indian
male population was 381-1565 cells/μL and for female
population was 447-1846 cells/μL.
CD4 + T cell percentage
The overall mean CD4 percentage was 38% (median
37%, range: 14-60%). The CD4 percentages were signifi-
cantly higher in female participants (mean ± SD: 39 ±
6%, median 39%) than male participants (mean ± SD: 36
± 6%, median 36%). The CD4 percentages were signifi-
cantly higher in female in all the regions (Table 2).
When the region wise data on CD4% was analysed, the
CD4% from the eastern region (mean CD4%: 35 ± 6,
median: 35%) was significantly lower than the CD4%
from other parts of the country (mean CD4%: 36 ± 6
and 37 ± 6, median: 36% and 37%) The 2.5% and 97.5%
covering 95% of the population was considered to be
the reference range for CD4 percentages. The reference
Table 1 Inter equipment comparison between FACSCalibur and EPICS XL-MCL using the stabilized blood samples
Immuno Trol Lot# 7587024 (N = 30) UKNEQAS proficiency samples(N = 22)
r value %CV r value %CV
Absolute CD4 count(cells/μL) 0.917 5.17 0.975 7.19
CD4 percentage 0.891 7.04 0.993 4.6
The inter equipment comparison between FACSCalibur and EPICS XL-MCL was conducted using the stabilized blood samples. The r values (range: 0.89 to 0.99)
were acceptable. The % CV (range: 4.6 to 7.1) were > 10% and hence acceptable.
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Figure 1 The figure showed the frequency distribution of
absolute CD4 counts in healthy Indian adults. The × axis shows
the absolute CD4 counts and the Y axis shows the number of
participants. The blue and red bar represents the number of male
and female participants respectively.
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and for female population was 27-54%.
Absolute CD3 count and percentages
The overall mean absolute CD3+ T cell count was 1692 ±
548 cells/μL (median 1628, range: 457-3926 cells/μL) and
the mean CD3 percentage was 69 ± 6.9% (median 69%,
range: 55-81%). The absolute CD3 + T cell counts and
percentages in female participants were significantly
higher than CD3+ T cell counts in male (mean absolute
CD3 counts: 1769 ± 571 in female and 1625 ± 516 in
m a l e ,p<0 . 0 0 0 1a n dm e a nC D 3 % :7 0±7i nf e m a l ea n d
67 ± 7.2% in male participants, p < 0.001). The CD3
counts of the participants from Southern region (mean:
1899+508, median: 1860 cells/μL) were significantly
higher than the CD3 counts of the participants from the
other regions with the lowest CD3+ T cell counts in the
participants from the Eastern region(mean: 1504 ± 500,
median: 1418 cells/μL). Whereas the CD3% from the
eastern region (mean: 67+7.2, median: 68%) was signifi-
cantly lower than the CD3% from other parts of the
country (mean: 70 ± 6.5, 70 ± 6.6 and 70 ± 6.9, median:
70%). The reference range (2.5% and 97.5% percentile
covering 95% of the population) for absolute CD3+ T cell
count for Indian male population was 776-2785 cells/μL
and for female population was 826-2997 cells/μL. The
reference range for CD3% for Indian male population
was 54-81% and for female population was 56-81%.
Influence of the social, demographic and other factors on
CD4 count and percentages
The absolute CD4+ T cell counts and percentages did
not differ significantly in the individuals with habitual,
occasional or no alcohol consumption (p > 0.05 within
all groups). The smoking habits of the enrolled partici-
pants did not seem to influence the absolute CD4+ T
cell counts and percentages (p > 0.05, for all groups)
(Table 3). The diet habits (vegetarian or non-vegetarian)
and marital status did not show any influence, however
the income had shown to influence the absolute CD4 +
T cell counts and percentages. The CD4 + T cell counts
and percentages were significantly higher in individuals
with high income (mean and median absolute CD4
count: 1168 and 1167 cells/μL respectively, mean and
median CD4%: 40%) as compared to the participants
reported to have medium level income (mean absolute
CD4 count: 931 and median: 858 cells/μL, mean and
median CD4%: 38%) and low level income (mean abso-
lute CD4 count: 734 and median: 781 cells/μL, mean
and median CD4%:36%) (Table 3). The absolute CD3
counts and percentages were not influenced by the alco-
hol consumption, smoking, diet habits and income (P >
0.05 in all cases)
Discussion
We have established the national reference range for
CD4+ T cell subset, both for CD4 percentages and
absolute CD4+ T cell counts, using the uniform proto-
col at eight centres across the country and enforcing
strict quality control for a single-platform method. We
have used the lyse-no wash procedure for CD4+ T cell
count estimation which has been reported to control the
inter laboratory variation [15]. This has reduced the
chances of the variability. All the seven sites used FACS-
Calibur for absolute CD4 count enumeration while the
E P I CX Lf l o wc y t o m e t e rf r o mC o u l t e rw a su s e da to n e
Table 2 The absolute CD4 count and percentages in the adult Indian population
Male Female Total
Region N Mean ±
SD
Median 2.5
th -97.5
th
percentile
N Mean ±
SD
Median 2.5
th -97.5
th
percentile
P value N Mean ±
SD
Median 2.5
th -97.5
th
percentile
Absolute CD4 count (cells/μL)
East 187 782 ± 249 756 352-1387 118 827 ± 267 759 418-1587 0.02 305 808 ± 255 773 426-1367
West 160 890 ± 280 853 452-1602 142 1020 ± 323 964 499-1916 0.002 302 952 ± 307 918 484-1646
North 156 825 ± 271 778 354-1551 143 951 ± 343 907 368-1895 0.0009 299 885 ± 316 831 381-1590
South 142 931 ± 271 931 389-1649 158 1139 ± 322 1116 586-1977 < 0.0001 300 1039 ± 315 1017 538-1701
Total 645 852 ± 273 822 381-1565* 561 995 ± 335 953 447-1846* < 0.0001 1206 919 ± 311 877 448-1611
CD4 Percentage
East 187 35 ± 6 35 24-48 118 38 ± 6 37 27-50 0.001 305 36 ± 6 36 25-48
West 160 37 ± 6 37 25-48 142 40 ± 7 40 28-54 < 0.0001 302 38 ± 7 38 27-50
North 156 37 ± 6 36 27-51 143 39 ± 6 39 28-54 0.0011 299 38 ± 6 38 27-52
South 142 36 ± 6 36 25-48 158 40 ± 6 40 28-54 < 0.0001 300 38 ± 7 38 27-52
Total 645 36 ± 6 36 25-49* 561 39 ± 6 39 27-54* < 0.0001 1206 38 ± 7 37 27-51
The table showed the mean, median and 2.5
th -97.5
th percentile values of the absolute CD4 counts and percentages form the adult Indian population. The region
wise and gender wise values of CD4 counts and percentages have been given. The absolute CD4 counts and percentages form female and male participants
were compared using the Mann Whitney’s non parametric t test and found to be significantly higher in female participants.
*: The reference ranges as shown by 2.5
th -97.5
th percentile have been mentioned in bold.
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equipment variability between these two equipment was
determined using the stabilized blood samples. The per-
cent CV was found to be very good, below 10%. The
variability was also determined during the study using
the samples received from UKNEQAS for proficiency
and the %CV was found to be less than 10% making the
results from both the equipments comparable. The
blood sample was uniformly collected in the morning to
reduce the diurnal variation as the diurnal variation is
reported to add as high as 20% variation in the CD4+ T
cell counts [16].
Since India is a heterogeneous country, similar num-
ber of participants from all four geographical areas was
ensured. The representation from all adult age groups
was also ensured. Hence, this multicentric study cover-
ing the entire country gave the opportunity to assess the
differences in CD4+ T cell counts in different popula-
tions in India. The sample size of the study was in
accordance with the rigorous CLSI guidelines for deter-
mining laboratory reference ranges, which recommends
a minimum of 153 subjects for a 95
th percentile clinical
reference range determination with 95% confidence [17].
The values of CD4 counts obtained in the present study
were compared with the values reported in from other
parts of the world (Table 4). The overall mean absolute
CD4+ T cell counts and percentages obtained in the
study were comparable to the values reported from Cau-
casian populations [18,7], British [19] and Dutch popula-
tions [6], Thai population (910 ± 310 cells/μL) [20] and
population from Nigeria (861 cells/μL) [21].
The values obtained in present study were higher than
t h ea b s o l u t eC D 4 +Tc e l lc o u n t so fC h i n e s ep o p u l a t i o n
(median 730 cells/μL) [22] and the values reported from
a few African countries such as Tanzania (median 723
cells/μL) [23], and Botswana (median 726 cells/μL) [24].
Whereas higher CD4 counts have been reported in
adult healthy populations from Uganda [25] and Turkey
[26] as compared to the CD4 counts reported in the
present study. These differences might be due to the
racial and ethnic variations within the populations and
also due to the differences in the methodologies where
the variations were not controlled. The use of standar-
dized procedures, calibrated controls and successful par-
ticipation of all participating centres in external quality
assurance programmes in the present study has made it
possible to control the variations and generate robust
reference values.
Both the absolute CD4+ T cell counts and percentages
were significantly higher in female than male population,
Table 3 Influence of Age, Income status, smoking and alcohol consumption on absolute CD4 count and percentages
N CD4 count(Cells/μL) CD4 percentage
Mean ± SD Median P value Mean ± SD Median P value
Age
< 18 1 1728 1728 —— 52 52 —
18-24 270 911 ± 306 873 38 ± 7 38
25-40 766 895 ± 295 842 < 0.001 37 ± 6 37 0.01
41-60 168 1034 ± 357 994 39 ± 7 38
≥ 61 1 1201 1201 — 34 34 ——
Marital status
Married 723 924 ± 326 876 0.706 38 ± 6 37 0.828
Unmarried/Single 428 916 ± 301 878 38 ± 6 37
Income status
High 102 1168 ± 368 1167 < 0.001 40 ± 7 40 < 0.001
Medium 900 931 ± 285 858 38 ± 6 38
Low 204 734 ± 289 781 36 ± 7 36
Alcohol Consumption
Habitual 5 770 ± 232 806 > 0.05 37 ± 10 37 > 0.05
Occasional 108 924 ± 278 900 38 ± 7 37
No 1091 919 ± 315 873 38 ± 6 37
Smoking
Habitual 29 958 ± 274 924 > 0.05 37 ± 7 38 > 0.05
Occasional 60 908 ± 316 861 38 ± 7 37
No 1115 919 ± 312 877 38 ± 6 37
The influence of age, marital and income status and habits like smoking and alcohol consumption on CD4 counts was assessed using the Mann Whitney’s U test.
The p values less than 0.05 considered to be significant.
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and not the influence of total lymphocyte counts that
might vary with the other infection load in the popula-
tion. The results supported the earlier finding from dif-
ferent population [7,24,27]. It has been suggested that a
sex hormone effect could be one possible explanation
for the reported gender difference in CD4+ T cell
counts [3]. Since the absolute CD4+ T cell count and
percentages in male and female populations differ signif-
icantly, it was felt appropriate to develop different refer-
ence rages for male and female population. We reported
difference reference ranges for male and female popula-
tion as 381-1565 cells/μL and 447-1846 cells/μL
respectively.
The absolute CD4 count reported from South India
were higher than other geographical region (mean 1039
± 315, median: 1017 cells/μL) and the CD4 counts from
East India were lower as compared to other geographi-
cal region (mean 808 ± 255, median: 773 cells/μL)
(Table 2). Similar results were obtained for the absolute
CD3 counts and percentages. The CD4 counts from
north India and west India were comparable. The CD4
counts reported in earlier studies showed a wide range
of 321-1800 cells/μL in Western Indians and 304-1864
cells/μL in North Indians [12] which was slightly lower
than the counts reported in the present study. Whereas
similar values were reported in two studies carried out
in eastern region [28,29]. The CD4 percentages reported
in Western Indian population in this study were similar
to the previous reports [30,31], however the values
reported in South Indian population were higher than
the previous report [11]. These observations may again
be attributed to the differences in the methodologies
across the studies.
In case of Eastern region, the absolute CD4+ T cell
counts from the participants from Regional Medical
Research Centre (RMRC,) Dibrugarh (all are from North
East)(Mean: 728 ± 250, median:688 cells/μL) and School
of Tropical Medicine, Kolkata (all from either west Ben-
gal or from Orissa)(mean: 888 ± 241, median: 873 cells/
μL) differed significantly. Since the CD4 percentages in
both these populations were similar (36%), the difference
could be attributed to the differences in the absolute
lymphocyte counts and not in the CD4+ T lymphocytes.
These differences might be due to the environmental,
genetic and nutritional factors [32-34] which needs to
be confirmed in a larger study within those populations.
The study showed no significant influence of alcohol
consumption or smoking on the CD4 counts; however
the number of habitual alcohol takers in this study was
very small. These findings were similar to previous
reports [11]. However the economic status; in terms of
monthly income, did show significantly higher absolute
CD4 counts and CD4 percentages in participants with
higher income. This probably indicates the importance
of the availability of nutritious food (might be vegetarian
or non vegetarian) with higher capacity to pay for it;
however this observation needs to be confirmed in a lar-
ger study.
T h ea b s o l u t eC D 4 +Tc e l lc o u n to f2 5 0c e l l s / μLi s
being used as a cut off value to initiate ART in the
National AIDS Control Programme (NACP) in India. In
the light of the availability of ‘test and treat strategy’ in
India or provision of ART at higher CD4+ T cell counts
in future it is necessary to know the lower reference
values in the population as this might influence the out-
come of the ART. In conclusion, the present study
established the national reference range for CD4 counts
Table 4 CD4 counts in normal healthy individuals from different countries/populations
Country/study population Mean Absolute CD4 count (cells/mm
3) Reference
Caucasian 1036 18
Caucasian 868 7
United kingdom 830 19
Dutch 993 6
Thais 910 20
Nigeria 861 21
Chinese population 727 22
Tanzania 746, median 723 23
Botswana 759, median 726 24
Uganda 1256 25
Turkey 1095, median: 1055 26
India Male: mean: 852 ± 273, median: 822
Female: mean: 995 ± 335, median: 953
Present study
The mean absolute CD4 counts obtained in different populations or countries have been summarized in the table. The mean and median CD4 counts if available
have been given in the table and the last column gives the reference in which the data has been published.
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Page 7 of 9in India as 381-1565 cells/μL for male population and
447-1846 cells/μL for female population. The reference
values for CD3 counts were 776-2785 cells/μLf o r
Indian male population and 826-2997 cells/μLf o r
female population. The reasons for lower CD4 count in
e a s t e r np o p u l a t i o ns h o u l db ee x p l o r e di na d d i t i o n a l
study in the target population. The reference ranges
could be useful in clinical management of the HIV
infection and various immunodeficiencies in India.
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